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Proliferation and differentiation of keratinocytes are normally well balanced, but this balance can be perturbed in
wound healing and is dysregulated in pathological conditions such as atopic dermatitis. Epithelial–mesenchymal
interaction affects this event via the cross-talk of cytokines and growth factors. Periostin, a matricellular protein,
has an important role during reepithelialization in wound healing and is critical for hyperproliferation of
keratinocytes in atopic dermatitis. Here we investigated how periostin regulates proliferation and differentiation
of keratinocytes in the epithelial–mesenchymal interactions using a three-dimensional organotypic air–liquid
interface coculture system. The release of IL-1a from keratinocytes and subsequent IL-6 production from
fibroblasts were critical for keratinocyte proliferation and differentiation. Periostin secreted from fibroblasts was
required for IL-1a-induced IL-6 production and enhanced IL-6 production by activation of the NF-kB pathway
synergistically with IL-1a. Thus, the combination of an autocrine loop of periostin and a paracrine loop composed
of IL-1a and IL-6 regulates keratinocyte proliferation and differentiation in the epithelial–mesenchymal
interactions, and periostin tunes the magnitude of keratinocyte proliferation and differentiation by interacting
with the paracrine IL-1a/IL-6 loop.
Journal of Investigative Dermatology (2014) 134, 1295–1304; doi:10.1038/jid.2013.500; published online 19 December 2013
INTRODUCTION
The epidermis, the outer layer of the skin, is composed of
stratified squamous epithelium and protects against environ-
mental insults and prevents body dehydration (Margadant
et al., 2010; Kern et al., 2011). This function is sustained via
keratin filament-anchoring intercellular junctions and lipids
contained within secretory granules. Production of all of these
components is strictly regulated depending on the differentia-
tion stages of keratinocytes. Thus, a fine balance between
proliferation and differentiation of keratinocytes is required to
maintain the histoarchitectural and functional features of the
epidermis. However, this homeostatic balance is perturbed in
wound healing and is dysregulated during pathological
conditions such as epidermal cancers, psoriasis, and atopic
dermatitis (Angel and Szabowski, 2002; Oyoshi et al., 2009).
Accumulating evidence using a three-dimensional organo-
typic coculture system supports the importance of the
epithelial–mesenchymal interactions in modulating keratino-
cyte proliferation and differentiation (Werner and Smola,
2001; Angel and Szabowski, 2002). In this system, keratino-
cytes show in vivo–like proliferation and differentiation phases
under the control of cocultured matrix-embedded fibroblasts.
Although many kinds of fibroblasts can be applied to this
system, the applied basal stem cells or progenitor cells are
likely to contribute to proliferation and differentiation of
keratinocytes (Aoki et al., 2004; Gangatirkar et al., 2007).
This system has the advantage of avoiding the high complexity
of in vivo models and has revealed the importance of the
cross-talk of cytokines and growth factors in the epithelial–
mesenchymal interactions. Particularly, it is well accepted that
the double paracrine loop composed of IL-1a/IL-1b from
keratinocytes and keratinocyte growth factor (KGF)/fibroblast
growth factor-7 or GM-CSF from fibroblasts is crucial in
epithelial–mesenchymal cross-talk (Maas-Szabowski et al.,
2000; Szabowski et al., 2000). However, we suggest that
this cross-talk between cytokines and growth factors in the
epithelial–mesenchymal interactions is potentially more com-
plex, and we set out to identify additional targets and further
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extend our current knowledge of the molecular mechanisms
involved.
Periostin (Postn), a matricellular protein, has recently
emerged as an important molecule for keratinocyte prolifera-
tion and differentiation. We and others showed that periostin
accelerates wound healing, based on the findings that perios-
tin was expressed in the granulation tissues beneath the
extended epidermal leading edges and that wound healing
was delayed in periostin-deficient mice (Nishiyama et al.,
2011; Elliott et al., 2012; Ontsuka et al., 2012). These studies
also demonstrated that periostin enhances proliferation of
keratinocytes and fibroblasts, as well as differentiation of fibro-
blasts into myofibroblasts, that would contribute to accelera-
ted wound healing. We furthermore found that periostin is
critical for hyperproliferation (acanthosis) and dysregulated
differentiation of keratinocytes in atopic dermatitis (Masuoka
et al., 2012; Shiraishi et al., 2012). Periostin production is
induced in dermal fibroblasts by IL-4 or IL-13, type 2 signature
cytokines highly produced in atopic dermatitis. Moreover,
wild-type (WT) fibroblasts, but not periostin-deficient fibro-
blasts, stimulated by IL-13 were able to induce keratinocyte
proliferation and differentiation in the three-dimensional
organotypic air–liquid interface (ALI) coculture system.
Accordingly, periostin was robustly expressed in the dermis
of atopic dermatitis patients and of house dust mite–induced
atopic dermatitis model mice. However, the molecular
mechanisms by which periostin contributes to keratinocyte
proliferation and differentiation have been largely elusive.
Here we investigated the molecular mechanism of periostin
involvement in epithelial–mesenchymal interactions. We con-
clude that the combination of an autocrine loop of periostin
and a paracrine loop composed of IL-1a and IL-6 regulates
keratinocyte proliferation and differentiation in the epithelial–
mesenchymal interactions. Our discovery of the interaction of
these loops provides a basic framework for the underlying
mechanism of reepithelialization in wound healing and
epithelial hyperproliferation in atopic dermatitis.
RESULTS
Identification of periostin-dependent soluble factors in the three-
dimensional organotypic ALI coculture system
We assumed that constitutive secretion of periostin from
fibroblasts might control keratinocyte proliferation and differ-
entiation (Figure 1a). We found that with twice the numbers of
keratinocytes compared with the previous study (from 2 106
cells/plate to 4106 cells/plate) in the absence of IL-13,
keratinocytes showed vigorous proliferation with numerous
proliferating cell nuclear antigen–positive cells and formation
of differentiated layers expressing cytokeratin-14 (a differentia-
tion marker for the stratum basale) and cytokeratin-10 (a
differentiation marker for the stratum spinosum and the
stratum granulosum) in the basal and suprabasal areas,
respectively (Figure 1b and c). In this culture condition,
keratinocytes seeded on gel-embedded periostin-deficient
fibroblasts showed significantly impaired proliferation and
differentiation. Furthermore, overexpression of periostin in
periostin-deficient fibroblasts restored keratinocyte prolifera-
tion and differentiation (Figure 1d), which is consistent with
the previous finding using recombinant periostin (Shiraishi
et al., 2012).
We hypothesized that periostin from fibroblasts causes
proliferation and differentiation of keratinocytes not by directly
acting on keratinocytes in the ALI coculture medium, but by
generating some keratinocyte growth–promoting soluble fac-
tor(s). To identify such factors, we compared the expression
levels of 40 different cytokines/chemokines in the conditioned
medium from the cocultures of keratinocytes with either WT
fibroblasts or periostin-deficient fibroblasts, using an antibody
array (Figure 1e). These conditioned media contained both
keratinocyte- and fibroblast-derived soluble factors. GM-CSF,
G-CSF, CXCL1/keratinocyte-derived chemokine, CXCL10/IFN-
g-induced protein 10, and CCL2/monocyte chemoattractant
protein-1 were abundantly produced. No significant differ-
ences were observed between these two conditioned media,
suggesting that production of these cytokines/chemokines is
independent of periostin. However, the production of IL-6 and
CXCL2/macrophage inflammatory protein-2, a neutrophil
chemoattractant, was significantly decreased in the periostin-
deficient fibroblast-conditioned medium compared with the
WT fibroblast medium, suggesting that production of these
factors depends on periostin. Decreased IL-6 in the periostin-
deficient fibroblast-conditioned medium was confirmed by
ELISA, and GM-CSF was similarly produced. The production
of G-CSF was not significantly different between WT and
periostin-deficient fibroblast-conditioned media (Figure 1f).
Although IL-1a was not clearly detected in the antibody array,
our ELISA analyses repeatedly demonstrated its unbiased
production in the culture media using both wild-type and
periostin-deficient fibroblasts (Figure 1e and f). The concentration
of KGF was relatively low compared with IL-6 (B200pgml 1
vs. B150 ng ml1), and the difference between WT and
periostin-deficient fibroblasts was o3-fold. These results
suggest that IL-6 is the most promising candidate keratinocyte
growth–promoting soluble factor that requires periostin in our
coculture system.
IL-6 is critical for proliferation and differentiation of
keratinocytes
Previous studies showed that IL-6, an important cytokine for
keratinocyte proliferation and differentiation, is abundantly
secreted in the three-dimensional coculture system of kerati-
nocytes and fibroblasts (Smola et al., 1993). However, to our
knowledge, it has not been formally demonstrated that IL-6
represents a major soluble factor that contributes to the
keratinocyte proliferation and differentiation in the ALI
coculture system. To assess the contribution of IL-6 in the
coculture system, we added neutralizing antibodies against
IL-6 alongside GM-CSF or G-CSF in the coculture system using
only WT fibroblasts. Blocking IL-6 activity significantly
reduced keratinocyte proliferation and differentiation,
whereas blocking of GM-CSF or G-CSF had no effect at all
(Figure 2a). Accordingly, adding recombinant IL-6 in the
coculture system using periostin-deficient fibroblasts restored
keratinocyte proliferation and differentiation in a dose-depen-
dent manner (Figure 2b). However, addition of KGF did not
restore these events (data not shown). These results clearly
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demonstrate that IL-6, which is produced dependently
on periostin, is critical for keratinocyte proliferation
and differentiation in the three-dimensional organotypic ALI
coculture system.
Fibroblasts are the cellular source of IL-6
To determine the cellular source of IL-6 in the coculture system,
we examined the expression of IL-6, as well as other keratino-
cyte growth–related factors, at the mRNA levels in monolayer
3D-ALI coculturea
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Figure 1. Identification of soluble factors in air–liquid interface (ALI) cocultures of keratinocytes with wild-type (WT) or Postn / fibroblasts. (a) A scheme of
the three-dimensional (3D) organotypic ALI coculture system. (b) Histology (hematoxylin and eosin (H&E)) and immunohistochemistry (proliferating cell nuclear
antigen (PCNA), cytokeratin-14 (CK14), and cytokeratin-10 (CK10)) of the ALI cocultures. (c) Numbers of PCNA-positive or -negative cells in basal areas in (b).
Data are shown as mean±SD in five views of 200mm length. (d) Histology (H&E) of the ALI cocultures with indicated fibroblasts. POSTN was retrovirally
transduced. (b, d) Bars¼ 20mm. (e) Results of antibody array analyses. AU, arbitrary units. (f) ELISA analyses of the indicated cytokines in the supernatants of the
ALI cocultures with WT and Postn / fibroblasts. KGF, keratinocyte growth factor; Postn, periostin. *Po0.05; **Po0.01; and NS, not significant.
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keratinocytes or fibroblasts cultured with the conditioned
medium derived from the ALI coculture of keratinocytes and
WT fibroblasts (Figure 3a). Expression of IL-6 was strongly
induced in the fibroblasts, but not in the keratinocytes
(Figure 3b). In contrast, GM-CSF, G-CSF, and IL-1a were
constitutively expressed in the keratinocytes, but not in the
fibroblasts, and CXCL2/macrophage inflammatory protein-2
were expressed in both cells, compatible with previous reports
(Ansel et al., 1990; Barker et al., 1991). Thus, we conclude that
fibroblasts are the cellular source of IL-6 in the coculture system.
IL-1a derived from keratinocytes is critical for IL-6 production in
fibroblasts
Given that IL-6 is a critical factor for keratinocyte proliferation
and differentiation and is secreted from fibroblasts in the
coculture system, we assumed that keratinocytes produce
some IL-6-inducing soluble factor(s) in the coculture system.
As it is known that IL-1a, GM-CSF, G-CSF, tumor necrosis
factor (TNF), and thymic stromal lymphopoietin (TSLP) are
derived mainly from keratinocytes (Figure 3b) and can all
induce the production of IL-6 (Ray et al., 1989; Sachs et al.,
1989; Shan et al., 2010), we tested the effects on IL-6
production of neutralizing antibodies against these factors.
Blocking IL-1a completely suppressed IL-6 production in the
coculture system, whereas blocking TNF, GM-CSF, G-CSF, or
TSLP did not affect IL-6 production (Figure 4a). Alternatively,
blocking IL-6, TNF, GM-CSF, G-CSF, or TSLP did not inhibit
IL-1a production, indicating a hierarchical relationship
between IL-1a and IL-6; IL-1a upregulates IL-6 production,
but not vice versa (Figure 4b). Accordingly, adding neutraliz-
ing antibodies against IL-1a in the coculture system signifi-
cantly suppressed keratinocyte and differentiation as did the
addition of neutralizing antibodies against IL-6 (Figure 4c).
Taken together, our results indicate that IL-1a secreted from
keratinocytes is a critical factor for IL-6 production in
fibroblasts and, therefore, for regulating keratinocyte prolifera-
tion and differentiation in the three-dimensional organotypic
ALI coculture system.
Periostin and IL-1a cooperate to induce IL-6 production in
fibroblasts via the NF-jB pathway
We next hypothesized that periostin produced by fibroblasts
would act on fibroblasts themselves in an autocrine manner
to promote IL-6 production by cooperating with IL-1a.
To explore this possibility, we first compared WT and
periostin-deficient fibroblasts for their capacity to produce
IL-6 in response to IL-1a. WT fibroblasts produced robust IL-6
upon stimulation with IL-1a dose dependently, whereas
periostin-deficient fibroblasts produced significantly lower
amounts of IL-6 (Figure 5a), consistent with the results from
the ALI cocultures (Figures 1e, f, and 4a). Transcriptional
expression of Il6 stimulated with IL-1a was downregulated in
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Figure 2. Functional validation of IL-6 as a major keratinocyte proliferation and differentiation factor. (a, b) Histology (hematoxylin and eosin (H&E)) and
immunohistochemistry with anti-CK10 and anti-CK14 antibodies of the air–liquid interface (ALI) cocultures. CK, cytokeratin; Postn, periostin. (a) ALI cocultures of
keratinocytes and wild-type (WT) fibroblasts in the presence of neutralizing antibodies against either IL-6, GM-CSF, or G-CSF, or control IgG. (b) ALI cocultures of
keratinocytes with Postn / fibroblasts in the presence of recombinant IL-6 (rIL-6) at the indicated concentration. (a, b) Bars¼ 20mm.
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periostin-deficient fibroblasts compared with WT fibroblasts,
as well as that of Cxcl2, Ccl5, and Ccl2, whereas the
difference of Fgf7 expression was not significant between
WT and periostin-deficient fibroblasts (Figure 5b). These
results demonstrate that the dependency on periostin is
variable among cytokines/chemokines/growth factors induced
by IL-1a and that IL-6 is a cytokine whose expression is
markedly dependent on periostin.
We then overexpressed periostin in a mouse fibroblast cell
line, NIH3T3, and analyzed the capacity for IL-6 production
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induced by IL-1a (Figure 5c). IL-6 production triggered by
IL-1a was significantly upregulated in periostin-transduced
fibroblasts compared with mock-transduced fibroblasts
(Figure 5d). To examine whether secreted periostin from
fibroblasts can indeed augment the ability to produce IL-6,
we next added conditioned medium from cultures with either
WT or periostin-deficient fibroblasts to freshly prepared WT or
periostin-deficient fibroblast cultures and assessed resultant IL-
1a-induced IL-6 production (Figure 5e). Adding conditioned
medium from WT fibroblasts partially restored IL-6 produc-
tion in periostin-deficient fibroblasts. Strikingly, conditioned
medium from WT fibroblasts also induced higher IL-6 produc-
tion in WT fibroblasts.
It was reported that IL-6 composes a positive loop for its
expression (Ogura et al., 2008). We therefore investigated
whether the regulation of IL-6 production by periostin is due to
this positive loop. Addition of neutralizing antibodies against
IL-6 partially inhibited IL-6 expression in WT fibroblasts, but
not to the level of that in periostin-deficient fibroblasts,
whereas addition of recombinant IL-6 upregulated IL-6
production in periostin-deficient fibroblasts, but not to the
level of that in WT fibroblasts (Supplementary Figure S1
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online). These results demonstrate that although the positive
loop of IL-6 is involved in IL-6 production by fibroblasts, this
alone cannot explain the exaggerated production of IL-6 by
periostin and IL-1a in these fibroblasts. Taken together, these
findings clearly indicate that secreted periostin regulates IL-6
production in fibroblasts by cooperating with IL-1a.
It is known that multiple signal pathways—including
NF-kB, NF-IL-6/the CCAAT/enhancer binding protein-b, and
signal transducer and activator of transcription 3 (STAT3)—act
on induction of IL-6 (Isshiki et al., 1990; Shimizu et al., 1990;
Zhang et al., 1990; Ogura et al., 2008). We and others have
also shown that periostin activates the NF-kB and STAT3
through integrin avb3 or avb5 in keratinocytes, fibroblasts,
and cancer cells (Bao et al., 2004; Shimazaki et al., 2008;
Nishiyama et al., 2011; Masuoka et al., 2012; Ontsuka et al.,
2012). We thus examined whether periostin and IL-1a
cooperate to activate the NF-kB and STAT3 pathways in
fibroblasts. IL-1a immediately activated IKKa/b by 5 minutes
and thereafter phosphorylation of IKKa/b slowly decayed in
WT fibroblasts, whereas the maximum phosphorylation of
IKKa/b was reduced and more rapidly decayed in periostin-
deficient fibroblasts (Figure 5f). In contrast, STAT3 was con-
stitutively activated and IL-1a stimulation attenuated its
phosphorylation in a similar time-dependent manner in both
WT and periostin-deficient fibroblasts, suggesting that STAT3
activation is not a major target of periostin in these cells.
Similarly, extracellular signal–regulated kinase-1/2 activation
was indistinguishable between WT and periostin-deficient
fibroblasts. We confirmed the significance of the IKKa/b–NF-
kB pathway in IL-6 production by adding an IKKa/b inhibitor,
PS-1145, in IL-1a-stimulated WT fibroblasts (Supplementary
Figure S2 online). These results establish that enhanced
activation of the NF-kB pathway in the presence of periostin
is an underlying mechanism cooperating with IL-1a on IL-6
production in fibroblasts.
DISCUSSION
In this study, we investigated how periostin mediates kerati-
nocyte proliferation and differentiation using a three-dimen-
sional organotypic ALI coculture system. We confirmed that
keratinocytes and fibroblasts are the cellular sources of IL-1a
and IL-6, respectively (Figure 3). Both periostin and IL-1a
released from fibroblasts and keratinocytes, respectively, are
critical for robust IL-6 production in fibroblasts (Figures 1 and
4). Periostin cooperates with IL-1a to induce IL-6 production
in fibroblasts by enhancing activation of the NF-kB pathway
(Figure 5). IL-6 released from fibroblasts has a critical role in
proliferation and differentiation of keratinocytes (Figure 2).
From these findings, we propose that the combination of the
autocrine loop of periostin and the paracrine loop composed
of IL-1a and IL-6 in epithelial–mesenchymal interactions is
critical in keratinocyte proliferation and differentiation
(Figure 6).
Periostin is only marginally expressed in the dermis on the
border of the epidermis in normal skin in humans and mice
(Zhou et al., 2010; Nishiyama et al., 2011; Masuoka et al.,
2012). As both periostin-deficient adults and embryos do not
appear to have any apparent defects in the epidermis (Rios
et al., 2005; Supplementary Figure S3 online), the role of
periostin in skin homeostasis and development is likely very
limited. In contrast, periostin is highly expressed in the
granulation tissues beneath the extended epidermal leading
edges (Nishiyama et al., 2011; Elliott et al., 2012; Ontsuka
et al., 2012) and in the dermis of both atopic dermatitis
patients and mice models of atopic dermatitis (Masuoka et al.,
2012). This suggests that the combination of the autocrine
periostin loop and the paracrine IL-1a/IL-6 loop could exert
their activity to enhance keratinocyte proliferation and differ-
entiation in the process of wound healing or pathological
conditions such as atopic dermatitis. Previous reports showing
that expression of IL-6 is upregulated in wound sites and that
wound healing is delayed in IL-6-deficient mice support this
notion (Kondo and Ohshima, 1996; Gallucci et al., 2000; Lin
et al., 2003). Our analyses in the wound repair model mice
showed that IL-6 was expressed adjacent to periostin-
expressing areas (Supplementary Figure S4 online), whereas
the spatiotemporal expression of periostin in wound sites is
strictly regulated: expression of periostin is transient and is
limited at the border of the wound sites (Zhou et al., 2010;
Nishiyama et al., 2011; Ontsuka et al., 2012). These data
suggest that periostin plays an important role in the spatio-
temporal regulation of IL-6 expression and then that of
reepithelialization within wound sites.
Periostin was initially characterized as a conventional
extracellular matrix protein that is important in fibrillogenesis
by interacting with fibronectin and tenascin-C (Kudo, 2011).
In parallel, multiple lines of evidence have shown that perio-
stin acts as a matricellular protein, defined as extracellular
matrix proteins that modulate cell functions by interacting
Keratinocytes
Proliferation and
differentiation
Periostin
IL-6
NF-κB
Fibroblasts
IL-1α
Figure 6. The autocrine loop of periostin (Postn) controls the paracrine loop
composed of IL-1a and IL-6 in the epithelial–mesenchymal interaction.
A schematic model of the epithelial–mesenchymal interaction shown in this
study. The paracrine loop composed of IL-1a and IL-6 derived from
keratinocytes and fibroblasts, respectively, in the epithelial–mesenchymal
interactions regulates proliferation and differentiation of keratinocytes that
crucially depend on an autocrine loop of periostin within fibroblasts. Periostin
cooperates with IL-1a on induction of robust IL-6 production in fibroblasts by
synergistically activating the NF-kB pathway.
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with cell surface receptors such as integrins. Periostin is involved
in cardiac development by promoting differentiation of
mesenchymal tissues (Norris et al., 2009); in tumorigenesis
by enhancing cell proliferation, angiogenesis, and metastasis
(Ruan et al., 2009); and in tissue repair in the vascular and
cardiac systems (Hamilton, 2008). The function of periostin in
the autocrine loop in the epithelial–mesenchymal interactions
shown in this study could constitute a periostin function as a
matricellular protein. The discovery of this synergistic interac-
tion between autocrine periostin loop and the paracrine IL-1a/
IL-6 loop has significance not only in the underlying mechan-
ism of keratinocyte proliferation and differentiation, but also in
the inflammation mechanism via periostin. We and others
have recently demonstrated that periostin is involved in the
pathogenesis of various inflammatory diseases, in addition to
atopic dermatitis, such as bronchial asthma (Takayama et al.,
2006), pulmonary fibrosis (Okamoto et al., 2011; Uchida
et al., 2012), IgG4-related sclerosing sialadenitis (Ohta et al.,
2012), eosinophilic otitis media (Nishizawa et al., 2012),
allergic rhinitis and chronic rhinosinusitis (Ishida et al., 2012),
proliferative diabetic retinopathy (Yoshida et al., 2011), and
scleroderma (Yang et al., 2012; Yamaguchi et al., 2013). It
appears possible that periostin is involved in the inflammatory
reactions in these diseases by inducing IL-6 production in
fibroblasts in combination with IL-1a.
MATERIALS AND METHODS
Cells
Mouse keratinocytes were prepared as described previously (Masuoka
et al., 2012). Mouse embryonic fibroblasts (MEFs) were obtained from
E14.5 embryos of Postnþ /þ and Postn / mice (Rios et al., 2005).
Postnþ /þ and Postn / MEFs were immortalized with SV40 large
T antigen. All experiments were performed in accordance with the
protocols approved by the Institutional Animal Care and Use Committee
and with the guidelines for care and use of experimental animals
required by the Japanese Association for Laboratory Animals Science
(1987).
Three-dimensional organotypic ALI coculture of keratinocytes
and fibroblasts
Mouse keratinocytes were cultured using a three-dimensional system
with a slight modification using 4 106 keratinocytes from a previous
report (Masuoka et al., 2012). The culture media accumulated from
day 3 to day 5 were subjected to ELISA.
Neutralization and stimulation of cytokine activities
Rat monoclonal antibodies against either mouse TSLP, G-CSF, IL-1a
(R&D Systems, Minneapolis, MN), IL-6, TNF (eBioscience, San Diego,
CA), or GM-CSF (BioLegend, San Diego, CA) were used to neutralize
cytokine activities at 10mg ml 1. Recombinant mouse IL-1a (Pepro-
Tech, Rocky Hill, NJ), IL-6 (BioLegend), and periostin (R&D Systems)
were used at the indicated concentrations.
Histological analysis
Keratinocyte growth in the organotypic ALI coculture system was
evaluated at day 7 by hematoxylin and eosin staining or immuno-
histochemistry, as previously described (Masuoka et al., 2012).
Antibodies used are described in the Supplementary Data online.
Antibody array
Conditioned medium obtained from three-dimensional organotypic
cocultures of keratinocytes with Postnþ /þ or Postn / MEFs at day 5
was analyzed with a Proteome Profiler mouse cytokine array kit panel
A (R&D Systems) according to the manufacturer’s instructions. Signal
intensity of each sample was normalized by those of positive controls.
ELISA
ELISA kits for mouse IL-1a (BioLegend), GM-CSF, IL-6 (eBioscience),
and G-CSF (PeproTech) were used. An ELISA kit for human KGF
(R&D Systems) was used for measuring mouse KGF concentrations
with mouse recombinant KGF (R&D Systems) as standard. To perform
mouse periostin ELISA, mouse anti-periostin mAbs (SS19A and
SS19C) were used as immobilized and tracer ones, respectively, that
were developed in-house, as described previously for human perios-
tin ELISA (Okamoto et al., 2011).
Quantitative real-time PCR
Total RNA was isolated using RNAiso PLUS (Takara Bio, Otsu, Japan)
and reverse-transcribed with the QuantiTect Reverse Transcription Kit
(Qiagen, Dusseldorf, Germany). The PCR reactions were performed
on a StepOnePlus Real-Time PCR System (Life Technologies,
Carlsbad, CA) using the THUNDERBIRD SYBR qPCR Mix (Toyobo,
Osaka, Japan). Threshold cycles of primer probes were normalized to
a housekeeping gene (glyceraldehyde-3-phosphate dehydrogenase
(GAPDH)), and relative values were calculated (Livak and
Schmittgen, 2001). Synthetic oligonucleotide primers are described
in the Supplementary Data online.
Overexpression of periostin
Human full-length POSTN complementary DNA (NM_006475)
was cloned from a fibroblast cell line, MRC-5 (Takayama et al.,
2006), and subcloned into pMXs-IG vector (Kitamura et al., 2003).
Mouse full-length Postn complementary DNA was cloned
(ENSMUST00000081564) from MEFs and subcloned into pMXs-puro
vector (Kitamura et al., 2003). Retroviral particles were produced by
co-transfecting HEK 293T cells with either pMXs empty vector or
periostin-carrying plasmid and amphotropic packaging plasmid pCL-
Eco (Naviaux et al., 1996) using calcium chloride. The supernatant
was collected on day 3 and used to infect Postn / MEFs or NIH3T3
cells. Successfully infected cells were sorted based on green fluorescent
protein expression (pMXs-IG) using FACSAria (BD Biosciences,
San Jose, CA) or selected with 5mg ml 1 puromycin (pMXs-puro).
Western blotting analysis
Western blotting was performed essentially as described previously
(Arima et al., 2010). Primary antibodies used are described in the
Supplementary Data online.
Statistical analyses
Statistical analyses were performed using the Prism 5.0 software
(GraphPad Software, La Jolla, CA). Data are presented as mean±SD.
The significance of differences was assessed using an unpaired
Student’s t-test. Values of Po0.05 were considered statistically
significant.
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